Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.    COM   CA14159U3010

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
07/22/2014 07/23/2014 07/24/2014 07/25/2014 07/28/2014 Date
7.24 7.3 7.27 7.27 7.25 Last
5825 12201 1420 5177 300 Volume
-1.36% +0.83% -0.41% 0.00% -0.28% Change
Company
Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world. Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent... 
Sector
Pharmaceuticals
Calendar
08/12Earnings Release
Surperformance© rating of Cardiome Pharma Corp.
Trading Rating : Investor Rating :
More about the company
Chart CARDIOME PHARMA CORP.
Duration : Period :
Cardiome Pharma Corp. Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Financials ( CAD)
Sales 2014 30,0 M
EBIT 2014 -12,9 M
Net income 2014 -13,3 M
Debt 2014 -
Yield 2014 -
Sales 2015 35,9 M
EBIT 2015 -6,32 M
Net income 2015 -1,01 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 3,99x
Capi. / Sales 2015 3,33x
Capitalization 120 M
More Financials
Latest news on CARDIOME PHARMA CORP.
07/18 CARDIOME PHARMA : Announces Closing Of Senior Secured Term Loan Facility
07/18 CARDIOME PHARMA : announces closing of senior, secured term loan facility
06/19 CARDIOME PHARMA : to Present At JMP Securities Healthcare
06/19 CARDIOME PHARMA : to Present at JMP Securities Healthcare Investor Conference
06/17 CARDIOME PHARMA : Announces Voting Results
06/17 CARDIOME PHARMA : announces voting results
06/11 CARDIOME PHARMA : to present at Bloom Burton & Co. Healthcare Investor Conferenc..
06/10 CARDIOME PHARMA : Announces Additional Director Nominee For 2014 AGM
06/10 CARDIOME PHARMA : Announces Additional Director Nominee for 2014 AGM
05/20 CARDIOME PHARMA : Announces Commercialization Partnership For AGGRASTAT® In Sele..
05/12 CARDIOME PHARMA : Reports First Quarter 2014 Financial Results
05/06 CARDIOME PHARMA : to hold first quarter 2014 financial results conference call o..
More news
Comments 
Advertisement
Income Statement Evolution
Cardiome Pharma Corp. : Income Statement Evolution
More Financials
EPS Revisions
Cardiome Pharma Corp. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF